Skip to main content

Plasmapheresis in multiple sclerosis: cerebrospinal fluid changes after treatment

  • Chapter
Immunological and Clinical Aspects of Multiple Sclerosis

Abstract

Although the pathogenesis of multiple sclerosis (MS) is unknown, much evidence suggests that MS is an immunologically mediated disorder in which demyelinating factors have been detected in serum and in cerebrospinal fluid (CSF)1–4. In MS sera ‘blocking factors’, possibly auto-antibodies, have been shown to affect nerve conduction in vitro 5. Unconcentrated CSF from MS patients in acute relapse can produce demyelination of tadpole optic nerves6. Moreover, circulating immune complexes have been described in MS7,8. Preliminary reports indicated a possible benefit from plasma exchanges (PE) in MS patients9,10. In order to study the effect of PE in CSF and serum IgG, we studied 18 MS patients, treated with a cycle of PE.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lisak, R.P., Zweiman, B. and Norman, M. (1975). Antimyelin antibodies in neurological diseases. Arch. Neurol., 32, 163

    Article  PubMed  CAS  Google Scholar 

  2. Bornstein, M.B. and Raine, C.S. (1977). Multiple sclerosis and experimental allergic encephalomyelitis: specific demyelination of CNS in culture. Neuropathol. Appl. Neurobiol., 3, 359

    Article  Google Scholar 

  3. Ryberg, B. (1978). Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy. J. Neurol. Sci., 38, 357

    Article  PubMed  CAS  Google Scholar 

  4. Panitch, H. S., Hooper, C. J. and Johnson, K. P. (1980). Cerebrospinal fluid antibody to myelin basic protein: measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch. Neurol., 37, 206

    Article  PubMed  CAS  Google Scholar 

  5. Schauf, C.L., Schauf, V., Davis, F.A. et al. (1978). Complement-dependent serum: neuroelectric blocking activity in multiple sclerosis. Neurology, 28, 426

    PubMed  CAS  Google Scholar 

  6. Tabira, T., Webster, H. de F. and Wray, S.H. (1976). Multiple sclerosis cerebrospinal fluid produces myelin lesions in tadpole optic nerves. N. Engl. J. Med., 295, 644

    Article  PubMed  CAS  Google Scholar 

  7. Tachovsky, T. G., Lisak, R.P., Koprowski, H. et al. (1976). Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet, 2, 997

    Article  PubMed  CAS  Google Scholar 

  8. Goust, J. M., Chenais, F., Carnes, J. E. et al. (1978). Abnormal T-cell population and circulating immune complexes in the Guillain-Barré syndrome and multiple sclerosis. Neurology, 28, 421

    PubMed  CAS  Google Scholar 

  9. Dau, P., Patajan, J.H., Johnson, K.P., Panitch, H.S. and Bornstein, M.B. (1980). Plasmapheresis in multiple sclerosis: preliminary findings. Neurology, 30, 1023

    PubMed  CAS  Google Scholar 

  10. Weiner, H.L. and Dawson, D.M. (1980). Plasmapheresis in multiple sclerosis: preliminary study. Neurology, 30, 1029

    PubMed  CAS  Google Scholar 

  11. Tourtellotte, W.W. and Booe, I.M. (1978). Multiple sclerosis: the blood-brain barrier and the measurement of de novo central nervous system IgG synthesis. Neurology, 28, 76

    PubMed  CAS  Google Scholar 

  12. Tibbling, G.H., Link, H. and Ohman, S. (1977). Principles of albumin and IgG analyses in neurological disorders. 1. Establishment of reference values. Scand. J. Clin. Lab. Invest., 37, 385

    Article  PubMed  CAS  Google Scholar 

  13. Mancini, G., Carbonara, A.D. and Heremans, J.F. (1956). Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry, 2, 235

    Article  Google Scholar 

  14. Lowenthal, W., Van Sande, M. and Karcher, D. (1960). The differential diagnosis of neurological diseases by fractionating electrophoretically the proteins. J. Neurochem., 6, 51

    Article  CAS  Google Scholar 

  15. Warren, K. G., Gordon, P.A. and McPherson, T. A. (1982). Plasma exchanges of malignant multiple sclerosis. J. Can. Sci. Neurol., 9, 27

    CAS  Google Scholar 

  16. Hauser, S. L., Dawson, D. M., Lehrich, J. R., Beal, M. F. et al. (1983). Intensive immunosuppression in progressive multiple sclerosis. N. Engl. J. Med., 27, 173

    Article  Google Scholar 

  17. Tindal, R.S.A. (1981). Plasmapheresis in multiple sclerosis: prospective randomized trial of pheresis and immunosuppression. Neurology, 31, 137

    Google Scholar 

  18. Bradshaw, P. (1964). The relation between clinical activity and the level of gamma globulin in the cerebrospinal fluid in patients with multiple sclerosis. J. Neurol. Sci., 1, 374

    Article  Google Scholar 

  19. Olsson, J.E., Link, H. and Muller, R. (1976). Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: Disability, duration and age of onset. J. Neurol. Sci., 27, 233

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 MTP Press Limited

About this chapter

Cite this chapter

Capparelli, R. et al. (1984). Plasmapheresis in multiple sclerosis: cerebrospinal fluid changes after treatment. In: Gonsette, R.E., Delmotte, P. (eds) Immunological and Clinical Aspects of Multiple Sclerosis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6352-1_31

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-6352-1_31

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-6354-5

  • Online ISBN: 978-94-011-6352-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics